Patents Assigned to Acelrx Pharmaceuticals, Inc.
  • Patent number: 11058856
    Abstract: An apparatus includes a housing and a pushrod. The housing defines a delivery passage and an exit port in fluid communication with the delivery passage. At least a portion of the pushrod is movably disposed in the delivery passage. A distal end portion of the pushrod is configured to move a drug dosage form through at least a portion of the delivery passage to convey the drug dosage form through the exit port when the distal end portion of the pushrod is moved from a first position to a second position. A surface of at least one of the pushrod or the housing defining the delivery passage is nonplanar, curved and/or contoured.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: July 13, 2021
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Edmond Chiu, Casidy Domingo
  • Publication number: 20210151153
    Abstract: Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 20, 2021
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Andrew POUTIATINE, Bruce EDWARDS, Charles RAMPERSAUD, Pamela PALMER, Bradley BLACKWOOD, Benjamin K. YAFFE
  • Patent number: 10896751
    Abstract: Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: January 19, 2021
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Andrew Poutiatine, Bruce Edwards, Charles Rampersaud, Pamela Palmer, Bradley Blackwood, Benjamin K. Yaffe
  • Patent number: 10709881
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: July 14, 2020
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • Publication number: 20200022918
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Application
    Filed: January 9, 2019
    Publication date: January 23, 2020
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, Andrew I. POUTIATINE
  • Patent number: 10507180
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 17, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 10342762
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: July 9, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, Andrew I. Poutiatine
  • Publication number: 20190125659
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 5, 2018
    Publication date: May 2, 2019
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Patent number: 10245228
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: April 2, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Publication number: 20190027241
    Abstract: Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
    Type: Application
    Filed: September 26, 2018
    Publication date: January 24, 2019
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Andrew POUTIATINE, Bruce EDWARDS, Charles RAMPERSAUD, Pamela PALMER, Bradley BLACKWOOD, Benjamin K. YAFFE
  • Publication number: 20180243169
    Abstract: Single dose drug dosage form dispensing devices, and methods for operating such devices are disclosed herein. In one embodiment, an apparatus includes a housing defining an actuation pathway and a pusher. At least a portion of the pusher is disposed within the actuation pathway such that a distal end portion of the pusher and a distal end portion of the housing define a volume configured to contain a drug-containing tablet. The pusher is configured to move relative to the housing in a distal direction from a first position to a second position to expel the drug-containing tablet from the volume. The distal end portion of the pusher is extended from an opening in the housing when the pusher is in its second position. The housing is configured to limit movement of the pusher relative to the housing in a proximal direction from the second position of the pusher towards the first position of the pusher after the drug-containing tablet is expelled from the volume.
    Type: Application
    Filed: April 27, 2018
    Publication date: August 30, 2018
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Casidy DOMINGO, Edmond CHIU, Bradley BLACKWOOD
  • Publication number: 20170259051
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Application
    Filed: May 8, 2017
    Publication date: September 14, 2017
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Andrew POUTIATINE, Charles RAMPERSAUD, Bruce EDWARDS, Edmond CHIU, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, William KOLOSI, Sascha RETAILLEAU
  • Patent number: 9744129
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: August 29, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 9642996
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 9, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • Publication number: 20170098057
    Abstract: Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
    Type: Application
    Filed: October 13, 2016
    Publication date: April 6, 2017
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Andrew POUTIATINE, Bruce EDWARDS, Charles RAMPERSAUD, Pamela PALMER, Bradley BLACKWOOD, Benjamin K. YAFFE
  • Publication number: 20160213606
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Publication number: 20160175533
    Abstract: An apparatus includes a housing and a pushrod. The housing defines a delivery passage and an exit port in fluid communication with the delivery passage. At least a portion of the pushrod is movably disposed in the delivery passage. A distal end portion of the pushrod is configured to move a drug dosage form through at least a portion of the delivery passage to convey the drug dosage form through the exit port when the distal end portion of the pushrod is moved from a first position to a second position. A surface of at least one of the pushrod or the housing defining the delivery passage is nonplanar, curved and/or contoured.
    Type: Application
    Filed: December 22, 2015
    Publication date: June 23, 2016
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Edmond CHIU, Casidy DOMINGO
  • Patent number: 9320710
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: April 26, 2016
    Assignee: AcelRX Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 9289583
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 22, 2016
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew I Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Larry Hamel
  • Publication number: 20150105424
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 16, 2015
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine